AOD-9604
5AD
Lyophilized peptide for use under a licensed healthcare provider. Choose single ampule/vial or box of 10. Sourced via Ares Technology Limited (Hong Kong) / Healthtide Biotech manufacturing list dated 7 October 2026. Specification: 5 mg × 10 vials.
- • Prescription / clinician-supervised pathway
- • Same LIRAVEXIN cart and checkout as pen packages
- • Not medical advice — individual suitability is determined by your clinician
Clinical reference (clinician-supervised)
Investigational and historical clinical exploration for fat metabolism and body composition. Evidence quality is limited compared with modern incretin therapies. Any clinic use is off-label/investigational framing under a licensed provider.
No established FDA-labeled human dosing. Published and historical clinic citations vary widely (often cited anecdotal SC ranges on the order of hundreds of micrograms to low milligrams daily)—clinician decides; do not treat catalog vial strength as a daily dose.
No established standard schedule.
Typically discussed as subcutaneous in clinic literature; not standardized.
Typical clinical / literature ranges under clinician supervision — not a prescription and not a DIY dosing guide. Individual dosing is determined solely by the treating clinician.
Liravexin USD for this pack (wholesale comparison · source × 3). Item is added to your shared cart for checkout coordination with your clinician pathway.
Or continue to checkout →